ANTHEM BIOSCIENCES
Back to Income Statement
|
ANTHEM BIOSCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹592 Cr | ₹451 Cr | ₹367 Cr | ₹385 Cr | ₹406 Cr |
What is the latest Consolidated Net Profit of ANTHEM BIOSCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹592 Cr |
| Mar2025 | ₹451 Cr |
| Mar2024 | ₹367 Cr |
| Mar2023 | ₹385 Cr |
| Mar2022 | ₹406 Cr |
How is Consolidated Net Profit of ANTHEM BIOSCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹592 Cr | 31.14 | |
| Mar2025 | ₹451 Cr | 22.86 | |
| Mar2024 | ₹367 Cr | -4.64 | |
| Mar2023 | ₹385 Cr | -5.02 | |
| Mar2022 | ₹406 Cr | - | |
Compare Consolidated Net Profit of peers of ANTHEM BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANTHEM BIOSCIENCES | ₹53,095.8 Cr | 0.9% | 7.7% | 15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
ANTHEM BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANTHEM BIOSCIENCES | 0.9% |
7.7% |
15.4% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses